sPD-1 is a soluble PD-1 variant linked to clinical and pathological features and disease progression in various autoimmune diseases, including systemic lupus erythematosus (SLE) and immunoglobulin A nephropathy (IgAN) (23, 24). Here, HOXD13 is linked to systemic lupus erythematosus.